Journal article
Gastrointestinal Side Effects with Erythromycin Preparations
Drug intelligence & clinical pharmacy, Vol.21(9), pp.734-738
09/1987
DOI: 10.1177/106002808702100914
PMID: 3498618
Abstract
This study was designed to determine the incidence and severity of gastrointestinal (GI) side effects in patients taking erythromycin. More patients complained of GI side effects with the enteric-coated tablet (70.8 percent) than with the stearate (51.4 percent) or the ethylsuccinate (48.9 percent) salts. The enteric-coated tablet was associated with a higher incidence of individual adverse reactions; more patients discontinued it because of adverse GI effects. These data demonstrate a high incidence of GI side effects to erythromycin. Additionally, GI side-effect incidence appears to be higher with the enteric-coated tablet.
Details
- Title: Subtitle
- Gastrointestinal Side Effects with Erythromycin Preparations
- Creators
- Barry L. Carter - University of IowaJerold C. Woodhead - University of IowaKatherine J. Cole - University of IowaGary Milavetz - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Drug intelligence & clinical pharmacy, Vol.21(9), pp.734-738
- DOI
- 10.1177/106002808702100914
- PMID
- 3498618
- ISSN
- 0012-6578
- eISSN
- 1542-6270
- Language
- English
- Date published
- 09/1987
- Academic Unit
- Pharmacy; Stead Family Department of Pediatrics; Pharmacy Practice and Science
- Record Identifier
- 9984365883002771
Metrics
8 Record Views